Hikal informs about inform press release

05 May 2021 Evaluate

Hikal has informed that it has enclosed a copy of the press release on 5th May 2021, titled ‘Hikal signs a 10-year multi product deal with a leading global pharmaceutical innovator company’ regarding long term contract entered into by the Company with a leading global pharmaceutical innovator company. Treat this as an intimation under Regulation 30 of SEBI LODR.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

256.15 22.65 (9.70%)
10-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.25
Dr. Reddys Lab 1251.10
Cipla 1489.15
Zydus Lifesciences 923.70
Lupin 2055.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×